Prevalence of diarrhoeal pathogens among children under five years of age with and without diarrhoea in Guinea-Bissau.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
09 2021
Historique:
received: 10 04 2021
accepted: 05 08 2021
revised: 11 10 2021
pubmed: 30 9 2021
medline: 15 12 2021
entrez: 29 9 2021
Statut: epublish

Résumé

Childhood diarrhoea, a major cause of morbidity and mortality in low-income regions, remains scarcely studied in many countries, such as Guinea-Bissau. Stool sample drying enables later qPCR analyses of pathogens without concern about electricity shortages. Dried stool samples of children under five years treated at the Bandim Health Centre in Bissau, Guinea-Bissau were screened by qPCR for nine enteric bacteria, five viruses, and four parasites. The findings of children having and not having diarrhoea were compared in age groups 0-11 and 12-59 months. Of the 429 children- 228 with and 201 without diarrhoea- 96.9% and 93.5% had bacterial, 62.7% and 44.3% viral, and 52.6% and 48.3% parasitic pathogen findings, respectively. Enteroaggregarive Escherichia coli (EAEC; 60.5% versus 66.7%), enteropathogenic E. coli (EPEC; 61.4% versus 62.7%), Campylobacter (53.2% versus 51.8%), and enterotoxigenic E. coli (ETEC; 54.4% versus 44.3%) were the most common bacterial pathogens. Diarrhoea was associated with enteroinvasive E. coli (EIEC)/Shigella (63.3%), ETEC (54.4%), astrovirus (75.0%), norovirus GII (72.6%) and Cryptosporidium (71.2%). The only pathogen associated with severe diarrhoea was EIEC/Shigella (p<0.001). EAEC was found more frequent among the infants, and EIEC/Shigella, Giardia duodenalis and Dientamoeba fragilis among the older children. Stool pathogens proved common among all the children regardless of them having diarrhoea or not.

Sections du résumé

BACKGROUND
Childhood diarrhoea, a major cause of morbidity and mortality in low-income regions, remains scarcely studied in many countries, such as Guinea-Bissau. Stool sample drying enables later qPCR analyses of pathogens without concern about electricity shortages.
METHODS
Dried stool samples of children under five years treated at the Bandim Health Centre in Bissau, Guinea-Bissau were screened by qPCR for nine enteric bacteria, five viruses, and four parasites. The findings of children having and not having diarrhoea were compared in age groups 0-11 and 12-59 months.
RESULTS
Of the 429 children- 228 with and 201 without diarrhoea- 96.9% and 93.5% had bacterial, 62.7% and 44.3% viral, and 52.6% and 48.3% parasitic pathogen findings, respectively. Enteroaggregarive Escherichia coli (EAEC; 60.5% versus 66.7%), enteropathogenic E. coli (EPEC; 61.4% versus 62.7%), Campylobacter (53.2% versus 51.8%), and enterotoxigenic E. coli (ETEC; 54.4% versus 44.3%) were the most common bacterial pathogens. Diarrhoea was associated with enteroinvasive E. coli (EIEC)/Shigella (63.3%), ETEC (54.4%), astrovirus (75.0%), norovirus GII (72.6%) and Cryptosporidium (71.2%). The only pathogen associated with severe diarrhoea was EIEC/Shigella (p<0.001). EAEC was found more frequent among the infants, and EIEC/Shigella, Giardia duodenalis and Dientamoeba fragilis among the older children.
CONCLUSIONS
Stool pathogens proved common among all the children regardless of them having diarrhoea or not.

Identifiants

pubmed: 34587158
doi: 10.1371/journal.pntd.0009709
pii: PNTD-D-21-00526
pmc: PMC8504977
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009709

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: JK is an employee of Mobidiag; the company did not sponsor the study nor did it have a role in study design, data collection and analyses, decision to publish, or preparation of the manuscript. All other authors declare no conflicts of interest.

Références

J Infect Dis. 2010 Sep 1;202 Suppl:S239-42
pubmed: 20684710
J Trop Med. 2015;2015:309648
pubmed: 26649055
Adv Exp Med Biol. 2000;478:77-93
pubmed: 11065062
Ann Trop Paediatr. 2001 Dec;21(4):313-8
pubmed: 11732149
Clin Infect Dis. 2012 Dec;55 Suppl 4:S303-11
pubmed: 23169942
J Infect Dis. 1994 Mar;169(3):581-7
pubmed: 8158030
Lancet. 2012 Jun 9;379(9832):2151-61
pubmed: 22579125
Sci Rep. 2019 Dec 12;9(1):19008
pubmed: 31831829
Lancet. 2013 Apr 20;381(9875):1405-1416
pubmed: 23582727
Trans R Soc Trop Med Hyg. 1987;81(5):860-4
pubmed: 3450011
J Clin Microbiol. 2003 Sep;41(9):4238-45
pubmed: 12958251
Clin Gastroenterol Hepatol. 2013 Oct;11(10):1300-1307.e3
pubmed: 23639597
J Infect Dis. 2002 Dec 15;186(12):1740-7
pubmed: 12447759
Epidemiol Infect. 2020 Mar 02;148:e64
pubmed: 32115003
Parasitol Res. 2012 Nov;111(5):2173-7
pubmed: 22915269
PLoS One. 2011 May 04;6(5):e19005
pubmed: 21572530
BMC Public Health. 2019 May 10;19(Suppl 3):469
pubmed: 32326914
Lancet. 2018 Feb 24;391(10122):801-812
pubmed: 29254859
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Pediatr Infect Dis J. 2018 May;37(5):424-428
pubmed: 28885460
Lancet. 2016 Sep 24;388(10051):1291-301
pubmed: 27673470
Infect Dis (Lond). 2017 Sep;49(9):655-663
pubmed: 28446068
Epidemiol Infect. 2018 Apr;146(6):688-697
pubmed: 29534766
Int J Infect Dis. 2000;4(1):8-13
pubmed: 10689208
Pediatr Infect Dis J. 2014 Oct;33(10):1037-42
pubmed: 25037040
PLoS One. 2016 Apr 26;11(4):e0146280
pubmed: 27116615
Environ Sci Pollut Res Int. 2016 Jul;23(14):13811-21
pubmed: 27126869
Pediatr Infect Dis J. 2007 Mar;26(3):233-7
pubmed: 17484220
PLoS One. 2016 Apr 19;11(4):e0153652
pubmed: 27092779
Int J Environ Res Public Health. 2018 Apr 05;15(4):
pubmed: 29621166
Trans R Soc Trop Med Hyg. 2009 Aug;103(8):839-45
pubmed: 19524992
Clin Microbiol Infect. 2012 Sep;18(9):901-6
pubmed: 21985619
Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):38-48
pubmed: 31084597
MMWR Morb Mortal Wkly Rep. 2017 Nov 03;66(43):1192-1196
pubmed: 29095805
Lancet Glob Health. 2015 Sep;3(9):e564-75
pubmed: 26202075
Pan Afr Med J. 2011;10 Supp 1:6
pubmed: 22359694
J Public Health Afr. 2011 Sep 05;2(2):e30
pubmed: 28299071
J Infect Dis. 2017 Dec 27;217(1):103-111
pubmed: 29099940
Clin Infect Dis. 2018 Jun 18;67(1):120-127
pubmed: 29351583
Euro Surveill. 2019 Jul;24(29):
pubmed: 31339096
Int J Infect Dis. 2015 May;34:90-5
pubmed: 25796432
Afr Health Sci. 2014 Dec;14(4):1001-11
pubmed: 25834513
PLoS Negl Trop Dis. 2009 Aug 25;3(8):e412
pubmed: 19707588
Clin Microbiol Infect. 2018 Aug;24(8):908.e9-908.e16
pubmed: 29133155

Auteurs

Sointu Mero (S)

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Suvi Timonen (S)

Division of Clinical Microbiology, Helsinki University Hospital, HUSLAB, Helsinki, Finland.

Tinja Lääveri (T)

Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Sandra Løfberg (S)

Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.

Juha Kirveskari (J)

Mobidiag, Espoo, Finland.

Johan Ursing (J)

Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
Department of Infectious Diseases, Danderyds Hospital, Stockholm, Sweden.

Lars Rombo (L)

Unit of Infectious Diseases, Uppsala University, Uppsala, Sweden.
Centre for Clinical Research, Sörmland County Council, Eskilstuna, Sweden and Uppsala University, Uppsala, Sweden.

Poul-Erik Kofoed (PE)

Bandim Health Project, Indepth Network, Bissau, Guinea-Bissau.
Department of Paediatrics and Adolescent Medicine, Lillebaelt Hospital, University Hospital of Southern Denmark, Kolding, Denmark.

Anu Kantele (A)

Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH